Joyce is an Entrepreneur, Leader, Corporate Development Executive & Investor with over 25 years of experience in Industry, Venture Capital and Wall Street with emerging companies. She has a track record of successfully leading diverse teams to execute acquisitions, complete venture investments, manage portfolios and deliver results. Prior experience includes senior roles at GlaxoSmithkline/SR One, Chiron Corporation and Cowen & Company.

Dr. Halperin is a physician-scientist, inventor, educator, and entrepreneur (BestDoctors, Mellitus, Bioambar). As a researcher at Harvard Medical School, he holds 40+ awarded or filed patents, several already licensed by Harvard University to companies working on bringing his inventions to the marketplace

Dr. Chorev is a scientist, chemist, inventor, educator, entrepreneur (Mellitus LLC, Biomabar and Avraham Pharmaceuticals) and faculty member at Brigham and Women’s Hospital – Harvard Medical School. Dr. Chorev has collaborated with Dr. Halperin for 15+ years on GCD59 & the development of the diagnostic test. Co-inventor of Novartis’ Exelon® (rivastigmine, approved) & Ladostigil, Phase II trials.

David is a finance professional with thirty years of experience covering all aspects of corporate finance. He is effective at working with management teams at the conceptual strategic level and at the detailed operational level, to help to define and communicate opportunities, risks, and strategies so that financial strategy truly supports overall strategy.

Bruce has over 36 years of Technical Management, and Operational and Research & Development experience in biotechnology, medical devices and diagnostics.
During his career in diagnostic assay and systems development, he has been responsible for developing over 60 biomarker assays that have been implemented on manual systems, bench top analyzers, and high-throughput automated systems.

Jerry is a commercially focused, experienced leader with a proven track record in the healthcare industry. He is skilled at establishing and communicating vision, developing strategies, executing tactical plans and empowering high-performing teams to achieve strategic objectives and deliver financial results.
Previously, Jerry was President & COO of Sekisui Diagnostics and Senior Vice President, Sales & Marketing of Genzyme Diagnostics.